Page last updated: 2024-11-13

balafilcon a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

balafilcon A: a contact lens material [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID91971246
MeSH IDM0514066

Synonyms (1)

Synonym
balafilcon a

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"To report differences in the incidence of adverse events and discontinuations found in a group of neophyte contact wearers using two different silicone hydrogel contact lenses on a daily- and continuous-wear basis during an 18-month period."( Adverse events and discontinuations during 18 months of silicone hydrogel contact lens wear.
Gilmartin, B; Santodomingo-Rubido, J; Wolffsohn, JS, 2007
)
0.34
" The incidence of adverse events, including corneal infiltrative events, superior epithelial arcuate lesions, and contact lens-induced papillary conjunctivitis, and discontinuations in each of the four contact lens groups were recorded."( Adverse events and discontinuations during 18 months of silicone hydrogel contact lens wear.
Gilmartin, B; Santodomingo-Rubido, J; Wolffsohn, JS, 2007
)
0.34
"Twenty-two adverse events were found."( Adverse events and discontinuations during 18 months of silicone hydrogel contact lens wear.
Gilmartin, B; Santodomingo-Rubido, J; Wolffsohn, JS, 2007
)
0.34
"Lotrafilcon A lenses were associated with a higher incidence of adverse events than balafilcon A lenses were, and this difference is attributed to the difference in the incidence of corneal infiltrative events."( Adverse events and discontinuations during 18 months of silicone hydrogel contact lens wear.
Gilmartin, B; Santodomingo-Rubido, J; Wolffsohn, JS, 2007
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (38)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (28.95)29.6817
2010's26 (68.42)24.3611
2020's1 (2.63)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.67

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.67 (24.57)
Research Supply Index3.93 (2.92)
Research Growth Index4.64 (4.65)
Search Engine Demand Index53.90 (26.88)
Search Engine Supply Index3.88 (0.95)

This Compound (25.67)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials12 (31.58%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other26 (68.42%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]